- Home
- RNA vs HRZN Comparison
RNA vs HRZN Comparison
Compare RNA & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNA | HRZN |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 227.6M | 195.5M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | RNA | HRZN |
|---|---|---|
| Price | $13.72 | $4.59 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 6 |
| Target Price | ★ $69.26 | $6.67 |
| AVG Volume (30 Days) | 381.5K | ★ 707.5K |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | N/A | ★ 28.63% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $88.12 | $12.25 |
| Revenue Next Year | $18.11 | $22.53 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.95 | $4.00 |
| 52 Week High | $73.06 | $8.81 |
Technical Indicators
Market Signals| Indicator | RNA | HRZN |
|---|---|---|
| Relative Strength Index (RSI) | 15.22 | 49.06 |
| Support Level | $13.06 | $4.01 |
| Resistance Level | $72.89 | $6.77 |
| Average True Range (ATR) | 0.50 | 0.15 |
| MACD | 2.01 | 0.13 |
| Stochastic Oscillator | 74.12 | 92.80 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.